AB
HZNP

AT Bancorp’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

AT Bancorp’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$668K Sell
25,277
-2,992
-11% -$70.9K 0.08% 129
2018
Q4 		$552K Sell
28,269
-229
-0.8% -$4.49K 0.07% 134
2018
Q3 		$558K Buy
28,498
+140
+0.5% +$2.66K 0.06% 150
2018
Q2 		$470K Buy
+28,358
New +$432K 0.05% 163

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AT Bancorp's HZNP Position: Q1 2019 in Review

AT Bancorp reduced its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 11% in Q1 2019, selling an estimated $70.9K and leaving 25,277 shares worth $668K. The position accounts for 0.08% of the portfolio, ranked #129.

AT Bancorp first reported a position in HZNP in Q2 2018 and has held it in 4 quarters since. 297 funds tracked by Wall St. Rank hold HZNP as of Q1 2019.

  • AT Bancorp held 25,277 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $668K as of Q1 2019.
  • AT Bancorp sold 2,992 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2019, an estimated $70.9K.
  • Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.08% of AT Bancorp's portfolio in Q1 2019, its #129 holding.
  • AT Bancorp first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2018 and has held it in 4 quarters since.
  • 297 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2019.

Based on AT Bancorp's 13F filing for Q1 2019, filed 13 May 2019.